Erectile Dysfunction Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A New Sildenafil Oral Film in Patients With Erectile Dysfunction
Condition: Erectile Dysfunction Interventions: Drug: Sildenafil Oral Film 50 mg; Drug: Sildenafil Oral Film 75 mg; Drug: Sildenafil Oral Film 100 mg; Drug: Placebo Sponsor: IBSA Institut Biochimique SA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2022 Category: Research Source Type: clinical trials

NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer
DiscussionNeuroSAFE PROOF is the first RCT of intra-operative frozen section during radical prostatectomy in the world. It is properly powered to evaluate a difference in the recovery of EF for men undergoing RARP assessed by patient-reported outcome measures. It will provide evidence to guide the use of the NeuroSAFE technique around the world.Trial registrationNCT03317990 (23 October 2017). Regional Ethics Committee; reference 17/LO/1978. (Source: Trials)
Source: Trials - July 22, 2022 Category: Research Source Type: clinical trials

Comparing The Effect of Tadalafil 5 mg/Day to Sildenafil 25 mg/Day on Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Erectile Dysfunction Patients; and Comparison of Clinical Response
Condition: Erectile Dysfunction and Neutrophil Lymphocyte Ratio Intervention: Drug: Tadalafil 5mg/sildenafil 25 mg Sponsor: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials